The DOI matches its Crossref record; 174 of the 176 references it cites were found in a registry or an index.
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Open accessPreprint — published as 10.3390/pharmaceutics10010034 · Paper page
Abstract
In the field of nasal delivery, one of the most fascinating applications is the delivery of drugs directly to the central nervous system bypassing the blood brain barrier. This approach would provide a series of benefits, such as dose lowering and direct targeting of potent drugs, ultimately reducing their systemic side effects. Recently, clinical trials have explored the nasal administration of insulin for the treatment of Alzheimer’s disease, with promising results. The use of nanomedicines could provide further options for making nose-to-brain delivery reality. In particular, apart from the selection of devices able to deposit the formulation in the upper part of the nose, surface modification of these nanomedicines appears the key strategy to optimize the delivery of drugs from the nasal cavity to the brain. In this review, nanomedicines delivery approaches based on surface electrostatic charges, mucoadhesive polymers, as well as chemical moieties targeting nasal epithelium, will be discussed and critically evaluated for nose-to-brain delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 (a) Nasal innervation; (b) Nose-to-brain (N2B) pathways of drug delivery (modified from [15,16] with permission).](/paper-figures/9c694c8f77f047b09bbaac04caee4c5a/surface-modified-nanocarriers-for-nose-to-brain-delivery-from-bioadhesion-to-figure-1.jpg)
![Figure 2 Dynamics of Alexa-dextran in brain tissue following nasal administration of hydrophobic (STR–CH2R4H2C) and hydrophilic (MPEG–PCL–CH2R4H2C) surface nanocarriers in: (a) whole brain and (b) 2 mm-sliced brain sections (reprinted with permission from [76]).](/paper-figures/886e42a0e82b4857b274c7cec00214eb/surface-modified-nanocarriers-for-nose-to-brain-delivery-from-bioadhesion-to-figure-2.jpg)
![Figure 3 Surface chemistry of nanoparticles having an influence on mucoadhesion (modified with permission from [84]).](/paper-figures/23424b355fb4411ea266e4fdefb4472f/surface-modified-nanocarriers-for-nose-to-brain-delivery-from-bioadhesion-to-figure-3.jpg)
![Figure 4 Fraction of total radioactivity recovered per organ 90 min after nasal administration to rats of (a) 99mTc-labelled simvastatin-loaded nanoparticles; (b) 99mTc-labelled simvastatin suspension [113].](/paper-figures/71bc71326e494e2db3fb6f83612d196d/surface-modified-nanocarriers-for-nose-to-brain-delivery-from-bioadhesion-to-figure-4.jpg)
![Figure 5 Major mechanisms hindering particles from diffusing through mucus: (a) Size filtering, by which only particles smaller than the mesh pores of the mucin fiber network can cross, whereas larger objects are blocked; (b) Interaction filtering, when particles behavior is different according to their surface properties: orange particles interacting strongly with the components of the mucus gel are trapped, whereas green particles showing weak interactions are allowed to go across (reproduced with permission from [121]).](/paper-figures/2c6044d4feb24bb5a48e289ed92519c9/surface-modified-nanocarriers-for-nose-to-brain-delivery-from-bioadhesion-to-figure-5.jpg)
![Figure 6 Distribution of wheat germ agglutinin (WGA)-conjugated quantum dots-loaded nanoparticles in various organs, 3 h after intranasal administration: (a) optical image (b) quantification of luminescence signals (adapted with permission from [153]. Copyright 2008 American Chemical Society).](/paper-figures/7d9838aa121545f0b9d3362424f43f1f/surface-modified-nanocarriers-for-nose-to-brain-delivery-from-bioadhesion-to-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“According to the present literature, different kinds of nanocarriers are used to prepare nasal formulations able to target the brain, constituted by polymer-based and lipid-based nanoparticles [21,22,23].”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ahmad, N., Ahmad, I., Umar, S., Iqbal, Z., Samim, M., & Ahmad, F. J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.941076 · Cited by 70
RetractedMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,863
Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,139
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,036
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 829
Cited by
Sorted by citations
Items 101–200 of 305
Paclitaxel Delivery to the Brain for Glioblastoma Treatment
Abdel-Haq, M., Kumar, A., Mohand, F.-E. A., Kravchenko‐Balasha, N., Rottenberg, Y., & Domb, A. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411722 · Cited by 33
Faisal, M. M., Gomaa, E., Ibrahim, A. E., Deeb, S. E., Al‐Harrasi, A., & Ibrahim, T. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02814-w · Cited by 32
Lee, D., Shen, A. M., Garbuzenko, O. B., & Minko, T. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00967-x · Cited by 35
Yang, W., Shi, Y., Zhang, Y., Yang, Y., Du, Y., Yang, Z., Wang, X., Lei, T., Xu, Y., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c09449 · Cited by 33
Trapani, A., Cometa, S., Giglio, E. D., Corbo, F., Cassano, R., Gioia, M. L. D., Trombino, S., Hossain, M. N., Gioia, S. D., Trapani, G., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010147 · Cited by 33
Zada, M. H., Kubek, M. J., Khan, W., Kumar, A., & Domb, A. J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.050 · Cited by 31
A consensus research agenda for optimising nasal drug delivery
Forbes, B., Bommer, R., Goole, J., Hellfritzsch, M., de Kruijf, W., Lambert, P., Caivano, G., Regard, A., Schiaretti, F., Trenkel, M., et al. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1714589 · Cited by 31
Self-citationZhou, C., Sun, P., Xu, Y., Chen, Y., Huang, Y., Hamblin, M. H., Foley, L. M., Hitchens, T. K., Li, S., & Yin, K. (2022) · Advanced Science · doi:10.1002/advs.202104986 · Cited by 31
Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport
Singh, S. R., Khurana, K., Chauhan, S. B., & Singh, I. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00530-z · Cited by 30
A comprehensive review of advanced nasal delivery: Specially insulin and calcitonin
Luo, D., Ni, X., Yang, H., Feng, L., Chen, Z., & Bai, L. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106630 · Cited by 30
Correia, A. C., Costa, I., Silva, R., Sampaio, P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124631 · Cited by 30
Sun, M., Qin, F., Bu, Q., Zhao, Y., Yang, X., Zhang, D., & Cen, X. (2025) · MedComm · doi:10.1002/mco2.70386 · Cited by 39
Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines
Milane, L. S., Dolare, S., Jahan, T., & Amiji, M. M. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102422 · Cited by 31
Lê, M. Q., Carpentier, R., Lantier, I., Ducournau, C., Dimier‐Poisson, I., & Betbeder, D. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.054 · Cited by 32
Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
Bicker, J., Fortuna, A. C., Alves, G., & Falcão, A. C. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115101544 · Cited by 30
Kim, K.-T., Lee, H. S., Lee, J.-J., Park, E. K., Lee, B.-S., Lee, J., & Bae, J. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0208 · Cited by 29
Cell and Tissue Instructive Materials for Central Nervous System Repair
Rocha, L. A., Silva, D., Barata‐Antunes, S., Cavaleiro, H., Gomes, E. D., Silva, N. A., & Salgado, A. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909083 · Cited by 31
Clementino, A., Marchi, C., Pozzoli, M., Bernini, F., Zimetti, F., & Sonvico, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716380 · Cited by 31
Self-citationGyarmati, B., Stankovits, G., Szilágyi, B. Á., Galata, D. L., Gordon, P. G., & Szilágyi, A. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112406 · Cited by 29
Nanocarriers Based Novel Drug Delivery as Effective Drug Delivery: A Review
Shirsath, N. R., & Goswami, A. K. (2019) · Current Nanomaterials · doi:10.2174/2405461504666190527101436 · Cited by 29
Hua, T., Li, S., & Han, B. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2339335 · Cited by 27
Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles
Butola, M., & Nainwal, N. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02946-z · Cited by 35
Chitosan nanoparticles for nasal drug delivery
Alghareeb, S., Ekenna, I. C., Asare‐Addo, K., Conway, B. R., & Adebisi, A. O. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106623 · Cited by 32
Dalvi, A. V., Ravi, P. R., Uppuluri, C. T., Mahajan, R. R., Katke, S., & Deshpande, V. S. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-020-00505-9 · Cited by 28
Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems
de Barros, C. T., Portugal, I., Batain, F., Portella, D. L., Severino, P. B., Cardoso, J. C., Arcuri, P., Chaud, M. V., & Alves, T. (2022) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqac003 · Cited by 29
Ashique, S., Afzal, O., Yasmin, S., Hussain, A., Altamimi, M. A., Webster, T. J., & Altamimi, A. S. A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122614 · Cited by 29
Vo, N. T. N., Huang, L., Lemos, H. D. P., Mellor, A. L., & Novakovic, K. (2020) · Journal of Applied Polymer Science · doi:10.1002/app.49259 · Cited by 27
Koduru, T. S., Gupta, N. V., Sharadha, M., Chakraborty, S., Kumar, H., Chand, P., Balamuralidhara, V., & Gowda, D. V. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103656 · Cited by 28
Mohi-ud-din, R., Mir, R. H., Mir, P. A., Banday, N., Shah, A. J., Sawhney, G., Bhat, M. M., Batiha, G. E., & Pottoo, F. H. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220817115003 · Cited by 26
Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders
Pan, R., Chen, D., Hou, L., Hu, R., & Jiao, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1184435 · Cited by 28
Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
Mwema, A., Muccioli, G. G., & Rieux, A. D. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.052 · Cited by 27
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
Wu, H., Li, C., Yuan, H., Zhao, J., & Li, S. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s520768 · Cited by 26
Gioia, S. D., Trapani, A., Cassano, R., Gioia, M. L. D., Trombino, S., Cellamare, S., Bolognino, I., Hossain, M. N., Sanna, E., Trapani, G., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120453 · Cited by 27
Hinge, N. S., Kathuria, H., & Pandey, M. M. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101303 · Cited by 25
Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G
Mwema, A., Bottemanne, P., Paquot, A., Učakar, B., Vanvarenberg, K., Alhouayek, M., Muccioli, G. G., & Rieux, A. D. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102633 · Cited by 26
Perrelli, A., Fatehbasharzad, P., Benedetti, V., Ferraris, C., Fontanella, M., Luca, E. D., Moglianetti, M., Battaglia, L., & Retta, S. F. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1873273 · Cited by 24
Polymeric nanoparticles for efficient nose-to-brain delivery
Bolon, M., Fieux, M., Monge, C., & Richard, S. (2025) · Nanoscale · doi:10.1039/d5nr00870k · Cited by 26
One, two, many: Strategies to alter the number of carbohydrate binding sites of lectins
Tobola, F., & Wiltschi, B. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.108020 · Cited by 24
Dubashynskaya, N. V., & Skorik, Y. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112980 · Cited by 25
Gangurde, P. K., Bhaskaran, N. A., & Kumar, L. (2018) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-018-9343-z · Cited by 25
Ghosh, S., Lalani, R., Patel, V., Bhowmick, S., & Misra, A. R. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1676721 · Cited by 25
Bigger or Smaller? Size and Loading Effects on Nanoparticle Uptake Efficiency in the Nasal Mucosa
Albarki, M. A. H., & Donovan, M. D. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01837-3 · Cited by 23
Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression
Leão, M. D. C., Pohlmann, A. R., Alves, A. D. C. S., Farsky, S. H. P., Uchiyama, M. K., Araki, K., Sandri, S., Guterres, S. S., & de Castro, I. A. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.016 · Cited by 23
Engineering advanced nanomedicines against central nervous system diseases
Shi, S., Ren, H., Xie, Y., Yu, M., Chen, Y., & Yang, L. (2023) · Materials Today · doi:10.1016/j.mattod.2023.08.005 · Cited by 25
Ahmad, E., Lv, Y., Zhu, Q., Qi, J., Dong, X., Zhao, W., Chen, Z., Wu, W., & Lü, Y. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100556 · Cited by 21
Wu, Y., Rakotoarisoa, M., Angelov, B., Deng, Y., & Angelova, A. (2022) · Nanomaterials · doi:10.3390/nano12132267 · Cited by 21
Tekade, A. R., Suryavanshi, M. R., Shewale, A. B., & Patil, V. (2023) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2023.2262035 · Cited by 21
Das, M., Sarma, A., Baruah, H., & Basak, D. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00057a · Cited by 23
Lee, D., Shen, A. M., Shah, M., Garbuzenko, O. B., & Minko, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910357 · Cited by 20
Jia, Y., Kong, X., Li, R., Wang, H., Chu-jie, L., Cheng, S., Duan, W., Xiao, Y., Mai, Y., Deng, W., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.036 · Cited by 20
Khezri, F. A. N. Z., Lakshmi, C. S., Bukka, R., Malviya, N., & Nargund, S. L. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.236 · Cited by 20
Kaneko, K., Osman, N., Carini, V., Scagnetti, G., & Saleem, I. Y. (2020) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-35910-2_3 · Cited by 20
Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 21
Lombardo, R., Ruponen, M., Rautio, J., Ghelardini, C., Mannelli, L. D. C., Calosi, L., Bani, D., Lampinen, R., Kanninen, K. M., Koivisto, A. M., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051554 · Cited by 20
Elawad, M. A., Ayaz, M., Mosa, O. F., Usman, A., Hamdoon, A. A. E., Almawash, S., Salim, L. H. M., Ahmed, A., & Elkhalifa, M. E. M. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400525 · Cited by 20
Yoo, S. H., Kim, H., & Lee, J. H. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221083414 · Cited by 21
Jadhav, K., Jhilta, A., Singh, R., Ray, E., Kumar, V., Yadav, A. B., Singh, A. K., & Verma, R. K. (2024) · Nanoscale · doi:10.1039/d4nr02621g · Cited by 19
Preparation and characterization of lamotrigine containing nanocapsules for nasal administration
Gieszinger, P., Csaba, N., García-Fuentes, M., Prasanna, M., Gáspár, R., Sztojkov‐Ivanov, A., Ducza, E., Márki, Á., Janáky, T., Kecskeméti, G., et al. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.003 · Cited by 19
Cubosomes for rheumatoid arthritis: enhancing anti-inflammatory drug delivery
Chandrakala, V., Bukke, S. P. N., Reddysushma, K., Likitha, J., Doreen, N., Thalluri, C., Goruntla, N., & Yadesa, T. M. (2025) · Discover Materials · doi:10.1007/s43939-025-00317-4 · Cited by 18
Kurano, T., Kanazawa, T., Iioka, S., Kondo, H., Kosuge, Y., & Suzuki, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122590 · Cited by 18
Sola, P., Krishnamurthy, P. T., Chintamaneni, P. K., Pindiprolu, S. K. S. S., & Kumari, M. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1779218 · Cited by 19
Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update
Pandey, M., Choudhury, H., Verma, R. K., Chawla, V., Bhattamisra, S. K., Gorain, B., Raja, M. A. G., & Amjad, M. W. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319999200819095620 · Cited by 18
Puri, A. V., Mohite, P. B., Khan, S., & Singh, S. K. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101463 · Cited by 17
Khan, T. T. S., Sheikh, Z., Maleknia, S. D., Oveissi, F., Fathi, A., Abrams, T., Ong, H. X., & Traini, D. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2387110 · Cited by 18
Nasal Delivery of Nanotherapeutics for CNS Diseases: Challenges and Opportunities
D’souza, A. A., Kutlehria, S., Huang, D., Bleier, B. S., & Amiji, M. M. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0311 · Cited by 17
Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management
Kataria, I., & Shende, P. K. (2022) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2022.105177 · Cited by 16
Assadpour, S., Akhtari, J., & Shiran, M. R. (2022) · PubMed Central · doi:10.22088/cjim.13.1.90 · Cited by 16
The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review
Zuglianello, C., & Lemos‐Senna, E. (2022) · Journal of Microencapsulation · doi:10.1080/02652048.2022.2051626 · Cited by 16
Fröhlich, E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050992 · Cited by 16
The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease
Cherait, A., Banks, W. A., & Vaudry, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082032 · Cited by 19
Polysaccharides: New Frontiers for Nasal Administration of Medicines
Clementino, A., Climani, G., Bianchera, A., Buttini, F., & Sonvico, F. (2025) · Polysaccharides · doi:10.3390/polysaccharides6010006 · Cited by 19
Self-citationCubosomes: evolving platform for intranasal drug delivery of neurotherapeutics
Gawarkar‐Patil, P., Mahajan, B., Pawar, A., & Dhapte-Pawar, V. S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00665-7 · Cited by 19
Veronesi, M. C., Graner, B. D., Cheng, S., Zamora, M. A., Zarrinmayeh, H., Chen, C.-T., DAS, S. K., & Vannier, M. W. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030391 · Cited by 14
Alves, A. D. C. S., Lavayen, V., Dias, A. D. F., Bruinsmann, F. A., Scholl, J. N., Cé, R., Visioli, F., Battastini, A. M. O., Guterres, S. S., Figueiró, F., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0169 · Cited by 15
Phongpradist, R., Thongchai, W., Thongkorn, K., Lekawanvijit, S., & Chittasupho, C. (2022) · Polymers · doi:10.3390/polym14030443 · Cited by 15
Agnihotri, T. G., Jadhav, G. S., Sahu, B., & Jain, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01173-y · Cited by 15
Nasal Bioadhesive Drug Delivery Systems and Their Applications
Badhe, R. V., & Nipate, S. S. (2020) · Wiley eBooks · doi:10.1002/9781119640240.ch10 · Cited by 16
Kumar, S., Yadav, A., Verma, R. K., Kumar, A., Gupta, P. K., & Shukla, R. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00386 · Cited by 14
Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development
Bonaccorso, A., Gigliobianco, M. R., Lombardo, R., Pellitteri, R., Martino, P. D., Mancuso, A., & Musumeci, T. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2177673 · Cited by 14
He, Y., Zhou, C., Jiang, S., Lan, W.-Q., Zhang, F., Tao, X., & Chen, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1292807 · Cited by 14
Ortiz, M., Coutinho, D. D. S., Ciambarella, B. T., de Souza, É. T., D’Almeida, A. P. L., Durli, T. L., Silva, P., Bernardi, A., Sonvico, F., Pohlmann, A. R., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00813-5 · Cited by 14
Self-citationModulation of olfactory area for effective transportation of actives in CNS disorders
Jain, H., Prabhakar, B. R., & Shende, P. K. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103091 · Cited by 15
Zuglianello, C., Silva, N. G. M., & Lemos‐Senna, E. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104527 · Cited by 13
Emerging paradigms in Alzheimer's therapy
Agnes Preethy, H., Rajendran, K., Sukumar, A. J., & Krishnan, U. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176872 · Cited by 15
Mittal, V., & Yadav, K. S. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2443165 · Cited by 15
Challenges and Future Perspectives of Nanotoxicology
Singh, S., Kumar, V., Datta, S., Singh, S., Dhanjal, D. S., Garg, R., Kaur, P., Sharma, K., & Singh, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-1702-0_22 · Cited by 13
Nose-to-brain drug delivery: Regulatory aspects, clinical trials, patents, and future perspectives
Pandey, A. P., Nikam, A. N., Basavraj, S., Mutalik, S. P., Gopalan, D., Kulkarni, S., Padya, B. S., Fernandes, G. J., & Mutalik, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00023-0 · Cited by 13
Razavi, R., khajouei, G., Divsalar, F., Dawi, E. A., & Amiri, M. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0086 · Cited by 14
Kouhjani, M., Jaafari, M. R., Saberi, A., Gholami, L., & Tafaghodi, M. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106857 · Cited by 13
Matías‐Guiu, J., Matías‐Guiu, J. A., Montero‐Escribano, P., Barcia, J. A., Canales-Aguirre, A. A., Mateos‐Díaz, J. C., & Gómez‐Pinedo, U. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00638 · Cited by 12
Intranasal gene therapy for the treatment of neurological disorders
Dhas, N. L., Mehta, T. A., Sharma, S., Garkal, A., Yadav, D., Hariharan, K., Shamjetshabam, B., Khot, S. V., Kudarha, R. R., Bangar, P., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00017-5 · Cited by 13
Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: A Review
Tseng, Y., Chen, T., & Liu, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s309937 · Cited by 13
Olatunji, T. L., Siebert, F., Adetunji, A. E., Harvey, B. H., Gericke, J., Hamman, J. H., & van der Kooy, F. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114476 · Cited by 12
Clementino, A., Velasco‐Estevez, M., Buttini, F., Sonvico, F., & Dev, K. K. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01109-3 · Cited by 12
Self-citationAli, M. M., Shoukri, R. A., & Yousry, C. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105693 · Cited by 13
Nanosystems at Nexus: Navigating Nose-to-Brain Delivery for Glioblastoma Treatment
Agnihotri, T. G., Dahifale, A., Gomte, S. S., Rout, B., Peddinti, V., & Jain, A. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00703 · Cited by 12
Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery
Patil, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00007-2 · Cited by 11
Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review
Kapoor, A., Hafeez, A., & Kushwaha, P. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230523114259 · Cited by 10
Li, G., Sun, X., Wan, X., & Wang, D. (2020) · Dose-Response · doi:10.1177/1559325820917836 · Cited by 11
Targeting glioblastoma through nano- and micro-particle-mediated immune modulation
Poot, E., Maguregui, A., Brunton, V. G., Sieger, D., & Hulme, A. N. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116913 · Cited by 11
Metadata
- Authors
- Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S.
- Affiliations
- University of Parma (IT)
- University of Ferrara (IT)
- Corresponding author
- Sonvico, Fabio
- ORCID
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-02-09
- Volume
- 10
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC5874847
- OpenAlex
- W2786145144
- Cited by
- 306
- References
- 176
- Citations by year
- 2026: 16 · 2025: 36 · 2024: 35 · 2023: 35 · 2022: 49 · 2021: 54 · 2020: 45 · 2019: 24 · 2018: 11
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (401196/2014-3, PVE 401196/2014-3)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- nose-to-brain delivery, intranasal drug delivery, nanocarriers, surface modification, blood-brain barrier bypass, mucoadhesion, mucoadhesive polymers, static electricity, insulin, Alzheimer's disease, brain drug delivery, particle engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review